Indicated for: tuberculosis
Route of administration: oral
Substance: pyrazinamide (anti-tuberculosis agent)
ATC: J04AK01 (Antiinfectives for systemic use | Drugs for treatment of tuberculosis | Other drugs for treatment of tuberculosis)
Pyrazinamide is an antitubercular medication used in the treatment of tuberculosis, particularly in the initial phase of combination therapy. It works by inhibiting the synthesis of fatty acids essential for Mycobacterium tuberculosis, contributing to bacterial destruction.
The medication is taken orally, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen and undergo regular tests to monitor liver function.
Patients should be aware of potential side effects, such as nausea, joint pain, or symptoms of liver damage. It is important to inform the doctor of any unusual symptoms.
Common side effects include nausea, joint pain, and elevated liver enzymes. In rare cases, severe reactions such as hepatitis or allergic reactions may occur. Patients should be informed of these risks before use.